BeiGene, Ltd. (ONC) reported $1.12 billion in revenue for the quarter ended March 2025, representing a year- over-year increase of 48.6%. EPS of $1.22 for the same period compares to -$2.41 a year ago. View all Key Company Metrics for BeiGene here>>> Shares of BeiGene have returned +15.4% over the past month versus the Zacks S&P 500 composite's +10.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term. Product revenue, ne ...